Folate receptor-mediated cervical staining as an adjunct to colposcopy which can improve the diagnostic accuracy of detecting high grade squamous intraepithelial lesions by Homola, Wojciech et al.
247
ORIGINAL PAPER /  G y N E cO LO G y
Ginekologia Polska
2020, vol. 91, no. 5, 247–250
Copyright © 2020 Via Medica
ISSN 0017–0011
DOI: 10.5603/GP.2020.0061
Corresponding author:
Wojciech Homola
2nd Department and Clinic of Gynaecology, Obstetrics and Neonatology, Wroclaw Medical University, Wroclaw, Poland
e-mail: wojtek.homola@gmail.com
Folate receptor-mediated cervical staining as an 
adjunct to colposcopy which can improve the 
diagnostic accuracy of detecting high grade squamous 
intraepithelial lesions
Wojciech Homola , Michal Pomorski , Aleksandra Zimmer , Pawel Baranski , Mariusz Zimmer
2nd Department and Clinic of Gynaecology, Obstetrics and Neonatology, Wroclaw Medical University, Wroclaw, Poland
ABSTRACT
Objectives: Cervical cancer is rated fourth in terms of incidence and cancer-related mortality in women. Cytology-based 
screening programs and colposcopy provided insufficient rates of detecting cervical intraepithelial neoplasia (CIN) prompt-
ing researchers to develop new tools. The aim of this study was to evaluate whether folate receptor-mediated staining is 
useful in detecting CIN2+ during gynecological examination with colposcopy.
Material and methods: In total 96 women with abnormal cytology findings were enrolled. The study was conducted on the 
Polish population. The diagnostic process consisted of colposcopy, receptor-mediated diagnosis (FRD), and histopathology 
examination. All women were subjected to the same diagnostic procedure.
Results: The patient mean age of 96 women was 38 ± 14.5 years. On colposcopy, high-grade lesions were detected in 
83 women. The FRD gave positive results in 63 women. Histopathology revealed 1 case of carcinoma plano epithelial akera-
todes, 21 cases of high-grade squamous intraepithelial lesions, 13 cases of low-grade squamous intraepithelial lesions. A total 
of 61 cases presented no pathology. FRD as an adjunct to colposcopy gave the following test results in detecting CIN2+ 
lesions: sensitivity — 94.29%, specificity — 46.67%, PPV — 50.77%, NPV — 93.33%, and accuracy — 64.21%. Using both 
techniques provided better results than using each of the tests alone. 
Conclusions: FRD is a promising test for the diagnosing CIN2+ cervical pathologies because it can increase the probability 
of detecting CIN2+ without any additional burden posed on patients. Further studies should be conducted on large and 
various populations to complement current evidence.
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INTRODUCTION
Cervical cancer is a considerable problem for women’s 
health. The estimated number of new cancer cases reached 
569,800, and the estimated number of deaths was 311,400 in 
2018 worldwide, which placed cervical cancer at the fourth 
position in terms of incidence and cancer-related mortality in 
women [1]. Increasing awareness and introduction of screen-
ing programs allowed to decrease morbidity and mortality 
rates due to cervical cancer [2]. In high-income countries, 
indices for cervical cancer are much lower than in low-income 
countries. For this reason, cervical screening is one out of 
three elements of the WHO global strategy towards eliminat-
ing cervical cancer worldwide as a public health problem [3].
Currently, many screening programs are based on cytol-
ogy [4]. However, this method is considered to be of insuf-
ficient and differentiated accuracy. An 11-year retrospective 
analysis of 999 cases published by Kang et al. reported 
a sensitivity of 97.14% and specificity of 85.58% for de-
tecting high-grade squamous intraepithelial lesion (HSIL) 
and squamous cell carcinoma (SCC) [5]. But the study by 
Wojciech et al. [6] on patients with histologically confirmed 
cervical intraepithelial neoplasia (CIN) showed a sensitivity 
of 58.02% and specificity of 63.28% in detecting CIN. For 
this reason, other noninvasive methods such as based on 
electrical impedance spectroscopy, folic acid receptor-me-
diated diagnosis (FRD) method, or those employing arti-
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ficial intelligence are of great interest [7–9]. The method 
based on FRD was developed after it had been discovered 
that the expression of the folate receptor α is increased 
not only in certain cells but also in many epithelial cancers 
[10]. Despite the FRD staining being a new method, the 
evidence is growing rapidly. Preliminary results show that 
this method is distinguished by simplicity, rapid provision 
of results, and effectiveness. Therefore, we undertook this 
study to add evidence on FRD. The aim of this study was to 
evaluate whether folate receptor-mediated staining is use-
ful in detecting CIN2+ during gynecological examination 
with colposcopy. 
MATERIAL AND METHODS
Women with abnormal cytology findings were enrolled 
in this study. All women were referred to our institution 
— an outpatient colposcopy clinic in a tertiary gynecology 
and obstetrics department. The study was conducted in 
the Department of Gynecology and Obstetrics, Wrocław 
Medical University, Wroclaw, Poland. Women who suffered 
from cancer of the cervix, had a vaginal bleeding or ac-
tive menstruation, had used vaginal contraceptives and 
vaginal medications up to 2 days before the enrollment 
were not included. All women gave the written informed 
consent for participation in the study and taking part in the 
diagnostic process to confirm or exclude CIN2+. The study 
was approved by the Commission of Bioethics at Wroclaw 
Medical University.
The diagnostic process consisted of colposcopy, FRD, 
and histopathology examination. Two experienced gynecol-
ogists were responsible for gynecology examinations and 
collection of specimens and data. One histopathologist with 
experience in the assessment of cervical pathology reviewed 
and interpreted biopsies. All study participants underwent 
the same diagnostic process.
For the conduct of colposcopy, the Videocolposcope 
HD-1000 with the IRIS software (Medicom, Wroclaw, Po-
land) was used. Images of the cervix were video recorded, 
both before and after the application of 3% acetic acid. 
FRD staining was done before visual inspection with ace-
tic acid (VIA). For staining, the folate receptor-mediated 
staining solution (Shaanxi Gaoyuan Medical Equipment 
Service Co., Ltd., Shaanxi, China) was used. A single-use 
foam applicator soaked in the FRD solution was placed 
on the cervix for 30 seconds and next, in the FRD colour 
changes on the applicator were assessed in comparison 
with FRD colour changes sheet. Results were classified as 
CIN2+ negative: for brown or green colors, while CIN2+ or 
worse for blue, dark blue or black. At each examination, 
2–3 targeted biopsies from the most suspected areas were 
taken. When there were no FRD induced colors changes, 
random biopsies were taken.
In the overall assessment, the case was considered to be 
negative for High-Grade Squamous Intraepithelial Lesions 
(HG-SIL) when the result of colposcopy was normal without 
any acetowhitening changes or any worse abnormalities; 
the FRD staining was brown or green, and histopathology 
samples were negative for HG-SIL (below CIN II). 
Collected data were statistically analyzed. Categorical 
variables were presented as numbers and percentages, 
while continuous data were presented as means with 
a standard deviation. Results between the two diagnostic 
methods (classical colposcopy and colposcopy + FRD stain-
ing) were compared with the Fisher’s exact test. To evaluate 
diagnostic tests, the following results were calculated: sen-
sitivity, specificity, positive predictive value (PPV), negative 
predictive value (NPV), and accuracy.
RESULTS
Overall, 96 women were eligible for the study. The pa-
tient population mean age was 38 years old with an SD of 
14.5 and range from 24 to 86 years. All study participants 
had abnormal cytology results which are summarized in 
Table 1. On colposcopy, high-grade lesions were detected in 
83 women. The FRD gave positive results in 63 women. Table 2 
shows the results of the histopathological examination. 
Positive and negative results of colposcopy, FRD and 
histopathology (Tab. 3) were used to calculate sensitivity, 
PPV, NPV, and accuracy (Tab. 4).
Table 1. Cytology results of referred women (n = 96)
Cytology diagnosis No of patients
1. Squamous cell carcinoma (SCC) 1
2. Atypical squamous cells cannot exclude HSIL (ASC-H) 14
3. AGC-US 6
4. Atypical squamous cells of undetermined significance (ASC-US) 18
5. High-grade squamous intraepithelial lesion (HSIL) 15
6. AIS 1
7. Low-grade squamous intraepithelial lesions (LSIL) 36
8. Negative for intraepithelial lesion or malignancy (NILM) 5
Table 2. Histopathological results of the study group (n = 96)
Lp. Histological diagnosis No of patients
1. Carcinoma plano epithelial akeratodes (G1) 1
2. High-grade squamous intraepithelial lesion (HSIL) 21
4. Low-grade squamous intraepithelial lesion (LSIL) 13
5. Normal 61
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DISCUSSION
Our study showed that colposcopies with an adjunct 
FRD have a sensitivity of 94.29%, specificity of 46.67%, 
PPV of 50.77% and NPV of 93.33%. Using both techniques 
leads to posing less destress on patients that would have 
a false-positive result with a colposcopy alone and limiting 
further unnecessary testing. Adding FRD to colposcopies el-
evates sensitivity of the examination from 37.14% to 94.29% 
increasing the probability that a test result will be positive 
when the disease is present. Our results may differ from 
those obtained in other studies because the study group 
consisted of women with abnormal cytology result referred 
to a tertiary diagnostic center which specializes in diagnosis 
and treatment of more complex conditions.
FRD is a novel technique employed in oncology. It is 
based on the discovery that the folate receptor (FR) expres-
sion is highly elevated in certain cells, including a variety 
of cancers [11]. Parker at al. [12] found positive expression 
of FR in certain types of ovarian carcinomas as well as in 
kidney, endometrium, lung, breast, bladder, and pancre-
atic cancers. Also, normal human tissues showed to have 
variability in FR expression. Normal human ovaries had 
a negligible expression of FR while this expression was high 
in normal human lung tissue. Liu et al. [13] investigated the 
expression of FRα and the role of FRα in the regulation of 
the ERK signaling pathway. They found that FRα expression 
was progressively increasing along with the progression of 
cervical lesions. In squamous cell carcinoma of the cervix, 
expression of proteins of ERK signaling pathway correlated 
with the expression of FRα. They concluded that expression 
of FRα is associated with the progression of cervical cancer 
and can regulate cervical cancer cells growth. 
Since the discovery of the link between FR and cer-
vical cancer, evidence on the potential role of FR in the 
detection of cervical metaplasia is growing rapidly. Sev-
eral studies conducted in the real clinical practice settings 
were published recently. Lu et al. [14] conducted a study on 
169 women and compared the results of FRD and cytology 
testing. They reported a sensitivity of 71.93%, specificity 
of 66.07%, PPV of 51.90%, and NPV of 82.22% of FRD in 
the diagnosis of cervical cancer and considered this result 
to be comparable to cytology. Li et al. [15] conducted the 
largest study up until now. They recruited 14,344 women 
from rural areas of China. In detecting CIN2+, FRD showed 
a sensitivity of 85.7%, specificity of 76.4%, PPV of 61.3%, and 
NPV of 92.5%. Authors concluded that FRD had a moderate 
agreement with cytology in detecting atypical squamous 
cells, was unable to exclude high-grade intraepithelial 
lesions, but was more sensitive than cytology. Xiao et al. 
[16] examined 404 women using FRD to screen them for 
high-grade cervical lesions. They found that the sensitivity of 
FRD in detecting CIN2+ was 80.00%, specificity was 51.92%, 
PPV was 24.19% and NPV 93.12%. Dai et al. [17] included 
216 women and subjected to FRD, human papillomavirus 
testing and ThinPrep cytology test. They reported the fol-
lowing test results for FRD: sensitivity — 80.41%, specificity 
— 68.29%, PPV — 60%, NPV — 85.5%. They concluded that 
FRD had significantly higher specificity than HPV testing 
and TCT, but no differences were noted in specificity. The 
recent study of Zhao et al. [18] recruited 1,504 patients with 
abnormal cytology and/or positive human papillomavirus 
(HPV) testing at primary screening. In this study, the sensi-
tivity of FRD was 77.72% and specificity of FRD was 60.02%. 
It is worth noting that the rate of detection of pathological 
lesions increased with the greater severity of the disease. 
FRD detected 45.45% of CIN1, 66.93% of CIN2, 84.44% of 
CIN3, and 98% of carcinomas. 
The results of our study are in line with the above-dis-
cussed reports from the literature. The advantage of our 
study lies in the evaluation of the benefit of FRD as an added 
value to the standard of care diagnosis in our institution, 
while most studies focus on presenting results of FRD alone 
in comparison to other diagnostic methods. Nevertheless, 
further studies should be conducted to further investigate 
the usefulness of FRD in detecting CIN2+ in clinical practice 
Table 3. Test calculations
Results of the test
Histopathology results
Positive Negative
Colposcopy
Positive n = 13 n = 0
Negative n = 22 n = 61
FRD
Positive n = 30 n = 33
Negative n = 5 n = 28
Colposcopy  
+ FRD
Positive n = 33 n = 32
Negative n = 3 n = 28
Table 4. Results of test evaluation
Colposcopy FRD Colposcopy + FRD
Sensitivity 37.14% (95% CI: 21.47–55.08)
85.71% (95% CI: 
69.74–95.19)
94.29% (95% CI: 
80.84%- 99.30)
Specificity 100.00% (95% CI: 94.13–100.00)
45.90% (95% CI: 
33.06–59.15)
46.67% (95% CI: 
33.67–60.00)
Positive 
Predictive 
Value
100.00% 47.62% (95% CI: 41.02–54.30)
50.77% (95% CI: 
44.53–56.98)
Negative 
Predictive 
Value
73.49% (95% CI: 
68.25–78.15)
84.85% (95% CI: 
70.41–92.95)
93.33% (95% CI: 
78.01–98.22)
Accuracy 77.08% (95% CI: 67.39–85.05)
60.42% (95% CI: 
49.92–70.25)
64.21% (95% CI: 
53.72–73.79)
CI — confidence interval
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settings. FRD is a simple technique with a rapid result which 
should be considered when adding this examination to the 
current standard of care. 
CONCLUSIONS 
FRD is a promising test for the diagnosing CIN2+ cervi-
cal pathologies because it can increase the probability of 
detecting CIN2+ without any additional burden posed on 
patients. Further studies should be conducted on large 
and various populations to complement current evidence. 
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